FDA approves Teva Pharmaceuticals’ CU method The U.S. Food and Drug Administration (FDA) approved a content uniformity (CU) method from Teva Pharmaceuticals that uses the Agilent TRS100 Raman quantitative pharmaceutical analysis system.Read More
Cell and gene therapy sector remains strong despite challenges: ARM CEO The cell and gene therapy sector is “quite strong” despite the regulatory, investment, and manufacturing challenges facing the industry, according to Janet Lambert, CEO of the Alliance for Regenerative Medicine (ARM). Lambert spoke with ScienceBoard.net about developments in the industry.Read More
Machine learning model opens door to real-time detection of cell therapy contamination Researchers at the Massachusetts Institute of Technology’s Singapore site have developed a new way to detect adventitious microbial contamination in mesenchymal stromal cell cultures. By using machine learning to predict if a culture is contaminated in near real-time, the approach could enable testing to take place during the production of cell therapy products.Read More
Bio-Rad debuts new chromatography column packs Bio-Rad Laboratories has launched EconoFit low-pressure prepacked chromatography column packs to support resin screening experiments in the development of protein purification workflows.Read More
Aizon unveils new data processing product Aizon debuted its new good practice-compliant data processing product, Aizon Digitize, which supports life sciences manufacturers with digitization, productivity, and avoiding time-consuming data inputs.Read More
Agilent wins 3 Scientists’ Choice Awards Aiglent Technologies has received three Scientists’ Choice Awards, including Best New Spectroscopy Product of 2021 for its Agilent 6560C Ion Mobility LC/Q-TOF.Read More
Sciex debuts Zeno Swath DIA, OS software Sciex has unveiled Zeno Swath data-independent acquisition (DIA), a digital record of a sample that can enable researchers to discover more potential biomarkers to be used in the development of clinical tests and in the discovery of new therapies. The firm also debuted its Sciex operating system (OS) software v3.0, a software that powers mass spectrometers across the Sciex portfolio.Read More